LOS ANGELES--(BUSINESS WIRE)--Life Stem Genetics Inc. (the “Company”), an emerging innovator in the advancement of Adult Stem Cell therapy announces that the Company's new stock symbol, LIFS, is now active. The Company is also pleased to release the general details of its recent financing commitment. This financing is for $1 million...
More...
